The financial and personal impact of migraines in the workplace is substantial. Effective management of workplace migraines includes screening, prevention, and effective treatment. Worksite screeners are available to detect the burden of undiagnosed migraine in the workplace. Decreasing the personal and financial impact of migraines in the workplace requires a variety of strategies predicated on collaborative efforts among workers, occupational health nurses, other providers, and management.
BurtonW. N.ChenC. Y.ContiD. J.SchultzA. B.EdingtonD. W. (2006). The association between health risk change and presenteeism change. Journal of Occupational and Environmental Medicine, 48(3), 252–263.
3.
BuseD.LiptonR. (2008). Assessment and management of the burden of migraine. In The impact of migraine: A focus on assessment and preventive therapy. Burlington, MA: Elsevier.
4.
DucharmeJ.BeveridgeR. C.LeeJ. S.BeaulieuS. (1998). Emergency management of migraine: Is the headache really over?Academy of Emergency Medicine, 5, 899–905.
5.
FriedmanB. W.GreenwaldP.BaniaT. C.EssesD.HochbergM.SolorzanoC. (2007). Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology, 69, 2038–2044.
6.
GoetzelR. Z.GuindonA. M.TurshenI. J.OzminkowskiR. J. (2001). Health and productivity management: Establishing key performance measures, benchmarks, and best practices. Journal of Occupational and Environmental Medicine, 43, 10–17.
7.
GoetzelR. Z.LongS. R.OzminkowskiR. J.HawkinsK.WangS.LynchW. (2004). Health, absence, disability and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. Journal of Occupational and Environmental Medicine, 46(4), 398–412.
8.
GreenbergP. E.FinkelsteinS. N.BerndtE. R. (1995). Economic consequences of illness in the workplace. Sloan Management Review, 36, 26–38.
9.
HahnS.CadyS. (2008). Post-diagnosis migraine evaluation: The importance of communication and the role of preventive intervention. In The impact of migraine: A focus on assessment and preventive therapy. Burlington, MA: Elsevier.
LoeppkeR.HymelP. A.LoflandJ. H.PizziL. T.KonickiD. L.AnstadtG. W. (2003). Health-related workplace productivity measurement: General and migraine-specific recommendations from the ACOEM Expert Panel. Journal of Occupational and Environmental Medicine, 45, 349–359.
12.
National Headache Foundation. (2007). The NHF unveils migraine prevention consensus statement. Retrieved October 10, 2008, from www.headaches.org
13.
RamadanM.SilbersteinS. D.FreitagF. G.GilbertT. T.FrishbergB. M. (2000). Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management for prevention of migraine. Retrieved October 10, 2008, from www.aan.com
14.
SaundersK.MerikangasK.LowN. C. P.Von KorffM.KesslerR. C. (2008). Impact of comorbidity on headache-related disability. Neurology, 70, 538–547.
15.
SilbersteinS.SaperJ.BerensonF.SomogyiM.McCagueK.D'SouzaJ. (2008). Oxcarbazepine in migraine headache. Neurology, 70, 548–555.
16.
StewartW. F. (2003). Online pain watch. Journal of the American Medical Association, 290, 2443–2454.
17.
WeaverM. B.MackowiakJ. I.SolariP. G. (2004). Triptan therapy impacts health and productivity. Journal of Occupational and Environmental Medicine, 46(8), 812–817.
